Managing the risk of invasive breast cancer in women at risk for breast cancer and osteoporosis: the role of raloxifene

Raloxifene hydrochloride is a selective estrogen receptor modulator (SERM) that has antiestrogenic effects on breast and endometrial tissue and estrogenic effects on bone, lipid metabolism, and blood clotting. Raloxifene significantly improves serum lipids and serum markers of cardiovascular disease...

Descripción completa

Detalles Bibliográficos
Autor principal: Vogel, Victor G
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2008
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2682393/
https://www.ncbi.nlm.nih.gov/pubmed/19281053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2682393/
https://www.ncbi.nlm.nih.gov/pubmed/19281053

Ejemplares similares